# A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

> **NCT02579031** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 1300 (actual)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Orsiro
- **DEVICE:** Xience

## Key facts

- **NCT ID:** NCT02579031
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-04
- **Final completion:** 2020-05
- **Target enrollment:** 1300 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579031, "A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02579031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*